These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 36068719)

  • 1. Pushing the boundaries of evaluation, diffusion, and use of medical devices in Europe: Insights from the COMED project.
    Torbica A; Tarricone R; Schreyögg J; Drummond M
    Health Econ; 2022 Sep; 31 Suppl 1():1-9. PubMed ID: 36068719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health technology assessment of medical devices: What is different? An overview of three European projects.
    Schnell-Inderst P; Mayer J; Lauterberg J; Hunger T; Arvandi M; Conrads-Frank A; Nachtnebel A; Wild C; Siebert U
    Z Evid Fortbild Qual Gesundhwes; 2015; 109(4-5):309-18. PubMed ID: 26354131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quo Vadis HTA for Medical Devices in Central and Eastern Europe? Recommendations to Address Methodological Challenges.
    Daubner-Bendes R; Kovács S; Niewada M; Huic M; Drummond M; Ciani O; Blankart CR; Mandrik O; Torbica A; Yfantopoulos J; Petrova G; Holownia-Voloskova M; Taylor RS; Al M; Piniazhko O; Lorenzovici L; Tarricone R; Zemplényi A; Kaló Z
    Front Public Health; 2020; 8():612410. PubMed ID: 33490024
    [No Abstract]   [Full Text] [Related]  

  • 4. Challenges in the Assessment of Medical Devices: The MedtecHTA Project.
    Tarricone R; Torbica A; Drummond M
    Health Econ; 2017 Feb; 26 Suppl 1():5-12. PubMed ID: 28139084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of coverage with evidence development schemes for medical devices: A decision tool for late technology adopter countries.
    Kovács S; Kaló Z; Daubner-Bendes R; Kolasa K; Hren R; Tesar T; Reckers-Droog V; Brouwer W; Federici C; Drummond M; Zemplényi AT
    Health Econ; 2022 Sep; 31 Suppl 1(Suppl 1):195-206. PubMed ID: 35322478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRIORITIES FOR HEALTH ECONOMIC METHODOLOGICAL RESEARCH: RESULTS OF AN EXPERT CONSULTATION.
    Tordrup D; Chouaid C; Cuijpers P; Dab W; van Dongen JM; Espin J; Jönsson B; Léonard C; McDaid D; McKee M; Miguel JP; Patel A; Reginster JY; Ricciardi W; Rutten-van Molken M; Rupel VP; Sach T; Sassi F; Waugh N; Bertollini R
    Int J Technol Assess Health Care; 2017 Jan; 33(6):609-619. PubMed ID: 29081308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a framework and decision tool for the evaluation of health technologies based on surrogate endpoint evidence.
    Ciani O; Grigore B; Taylor RS
    Health Econ; 2022 Sep; 31 Suppl 1(Suppl 1):44-72. PubMed ID: 35608044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating health care interventions in the European Union.
    McDaid D; Cookson R;
    Health Policy; 2003 Feb; 63(2):133-9. PubMed ID: 12543526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A scoping review of health economic evaluation in the World Health Organization Eastern Mediterranean region.
    Sharkawy MN; Dastan I
    Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):877-884. PubMed ID: 34024232
    [No Abstract]   [Full Text] [Related]  

  • 10. Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges.
    Federici C; Reckers-Droog V; Ciani O; Dams F; Grigore B; Kaló Z; Kovács S; Shatrov K; Brouwer W; Drummond M
    Eur J Health Econ; 2021 Nov; 22(8):1253-1273. PubMed ID: 34117987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novelties of the regulation on health technology assessment, a key achievement for the European union health policies.
    Pisapia A; Banfi G; Tomaiuolo R
    Clin Chem Lab Med; 2022 Jul; 60(8):1160-1163. PubMed ID: 35624072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health technology assessment for medical devices in Europe. What must be considered.
    Siebert M; Clauss LC; Carlisle M; Casteels B; de Jong P; Kreuzer M; Sanghera S; Stokoe G; Trueman P; Lang AW;
    Int J Technol Assess Health Care; 2002; 18(3):733-40. PubMed ID: 12391964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTA of medical devices: Challenges and ideas for the future from a European perspective.
    Fuchs S; Olberg B; Panteli D; Perleth M; Busse R
    Health Policy; 2017 Mar; 121(3):215-229. PubMed ID: 27751533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Policy developments of health technology assessment in the European Union].
    Baran-Kooiker A; Czech M; Hołownia-Voloskova M
    Postepy Biochem; 2019 Nov; 65(4):319-321. PubMed ID: 31945287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European network for Health Technology Assessment Joint Action (EUnetHTA JA): a process evaluation performed by questionnaires and documentary analysis.
    Woodford Guegan E; Cook A
    Health Technol Assess; 2014 Jun; 18(37):1-296. PubMed ID: 24913263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling approaches for histology-independent cancer drugs to inform NICE appraisals: a systematic review and decision-framework.
    Murphy P; Glynn D; Dias S; Hodgson R; Claxton L; Beresford L; Cooper K; Tappenden P; Ennis K; Grosso A; Wright K; Cantrell A; Stevenson M; Palmer S
    Health Technol Assess; 2021 Dec; 25(76):1-228. PubMed ID: 34990339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Health Economics' and the evolution of economic evaluation of health technologies.
    Hutton J
    Health Econ; 2012 Jan; 21(1):13-8. PubMed ID: 22147623
    [No Abstract]   [Full Text] [Related]  

  • 19. Testing a new taxonomic model for the assessment of medical devices: Is it plausible and applicable? Insights from HTA reports and interviews with HTA institutions in Europe.
    Fuchs S; Olberg B; Perleth M; Busse R; Panteli D
    Health Policy; 2019 Feb; 123(2):173-181. PubMed ID: 29703653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing a national HTA program for medical devices in Italy: Overhauling a fragmented system to ensure value and equal access to new medical technologies.
    Tarricone R; Amatucci F; Armeni P; Banks H; Borsoi L; Callea G; Ciani O; Costa F; Federici C; Torbica A; Marletta M
    Health Policy; 2021 May; 125(5):602-608. PubMed ID: 33820679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.